Short news for quality minds. Power your niche.Smartly curated short news for quality minds. Want your own niche feed? Integrate with us today.
China and Hong Kong stocks fell on Wednesday as investors got worried about the upcoming Trump-Xi meeting. Trade tensions with Europe also hurt sentiment. Many property shares gained after the government showed support for China Vanke. The CSI300 index fell 0.5% while the Hang Seng Index fell 0.8% by lunch.
Airtel Money announced on Wednesday that it intends to file for an initial public offering in London. The company delayed the listing from early 2026 to the second half due to market conditions. It now targets a valuation of $8 billion to $9 billion and will share more details in October.
Helios Mid Cap Fund led the list of top five midcap mutual funds with the highest mid and smallcap exposure in August 2026. The fund reached 60.1% exposure on August 31, 2026. Other funds like SBI, Franklin India, and WhiteOak Capital also showed high investments in these medium-sized company stocks.
Lalithaa Jewellery Mart share price hit a 5% upper circuit at ₹352.80 on the BSE on Wednesday, 23 September. The stock has gained 36% this month and is up 75% from its IPO price. Meanwhile, the company expanded its retail presence by opening its 66th showroom in Mayiladuthurai, Tamil Nadu.
Donald Trump said US and Iranian officials met Tuesday after he threatened to "annihilate" Iran at the UN General Assembly. Meanwhile, Apollo Global capped a private credit fund as investors pulled cash. Also, TRAI mandated that telecom operators issue special tariff vouchers for voice calls and SMS at lower costs.
Bajaj Finance shares gained nearly 2.5 per cent on Wednesday, becoming top gainers on Nifty 50 and BSE Sensex. The stock traded at Rs 1,033.80 at 10:42 am on September 23. Brokerages like Jefferies and UBS kept a positive view, as management showed confidence in long-term growth and strong asset quality.
Symbiotec Pharmalab targets 20-25% revenue and EBITDA growth by FY27. The company saw a slow first quarter but expects commercial milestones in the second half to help. A new ₹400 crore biotech vertical will start generating revenue by the fourth quarter. Chairman Anil Satwani said, "These are all procedural observations."
Bajaj Finance shares jumped 3% on Wednesday after global brokerages issued bullish calls. Jefferies maintained a Buy rating with a target of Rs 1,280, while UBS upgraded the stock to Neutral with a target of Rs 1,100. UBS said, "We believe India is entering a strong unsecured credit growth cycle."